ArticleBMC complementary medicine and therapies2023

Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach.

Jun Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.